Rationale: The genes encoding fibroblast growth factor (FGF) 8 and 10 are expressed in the anterior part of the second heart field that constitutes a population of cardiac progenitor cells contributing to the arterial pole of the heart. Previous studies of hypomorphic and conditional Fgf8 mutants show disrupted outflow tract (OFT) and right ventricle (RV) development, whereas Fgf10 mutants do not have detectable OFT defects. Objectives: Our aim was to investigate functional overlap between Fgf8 and Fgf10 during formation of the arterial pole. Methods and Results: We generated mesodermal Fgf8; Fgf10 compound mutants with MesP1Cre. The OFT/RV morphology in these mutants was affected with variable penetrance; however, the incidence of embryos with severely affected OFT/RV morphology was significantly increased in response to decreasing Fgf8 and Fgf10 gene dosage. Key Words: second heart field Ⅲ arterial pole defects Ⅲ pharyngeal arch artery defects M alformations of the arterial pole of the heart account for more than 30% of human congenital heart defects. 1 Remodeling of the outflow tract (OFT) plays a critical role in the maturation of the arterial pole. As the heart matures, cushion tissue is formed in the OFT, as a result of an epithelial-mesenchymal transformation. 2 Rotation and shortening of the OFT are accompanied by fusion of the cushions to form a septum that divides the OFT into the aorta and pulmonary trunk. Subsequent morphogenetic events result in alignment of the aorta with the left ventricle and the pulmonary trunk with the right ventricle (RV). 3 The OFT is derived from the anterior part of the second heart field (SHF), which in the mouse embryo, also contributes to the RV and ventricular septum. 4 -6 This field of splanchnic mesoderm initially lies medial to the cardiac crescent and then dorsally and anteriorly to the heart tube. In addition to myocardium, the SHF contributes smooth muscle to the base of the great arteries. 6,7 A second source of cells, namely cardiac neural crest (CNC), migrates from the neuroectoderm of the dorsal neural tube into the OFT and contributes to cushion formation and correct septation and alignment of the aortic and pulmonary outflows. 8 -10 CNC also interacts with the mesodermal cells of the SHF. 11 When CNC is ablated in the chick embryo, OFT elongation and looping of the cardiac tube is perturbed, leading to persistent truncus arteriosus and misalignment of the great arteries relative to the ventricles. 10 Many signaling pathways in the SHF, CNC, and pharyngeal region control development of the arterial pole of the heart by affecting specification, proliferation, survival and differentiation of progenitor cells. 12 SHF mesoderm also plays a role in the formation of the blood vessels that channel blood from the aorta and pulmonary trunk to the body and lungs. These arteries form within the third, fourth, and sixth pharyngeal arches, which are bilateral embryonic structures, consisting of surface ectoderm, inner endoderm, and a mesodermal core expressing SHF markers, that becomes surrounded by CNC. The endothelium of the pharyngeal arch Original
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alformations of the arterial pole of the heart account for more than 30% of human congenital heart defects. 1 Remodeling of the outflow tract (OFT) plays a critical role in the maturation of the arterial pole. As the heart matures, cushion tissue is formed in the OFT, as a result of an epithelial-mesenchymal transformation. 2 Rotation and shortening of the OFT are accompanied by fusion of the cushions to form a septum that divides the OFT into the aorta and pulmonary trunk. Subsequent morphogenetic events result in alignment of the aorta with the left ventricle and the pulmonary trunk with the right ventricle (RV). 3 The OFT is derived from the anterior part of the second heart field (SHF), which in the mouse embryo, also contributes to the RV and ventricular septum. 4 -6 This field of splanchnic mesoderm initially lies medial to the cardiac crescent and then dorsally and anteriorly to the heart tube. In addition to myocardium, the SHF contributes smooth muscle to the base of the great arteries. 6, 7 A second source of cells, namely cardiac neural crest (CNC), migrates from the neuroectoderm of the dorsal neural tube into the OFT and contributes to cushion formation and correct septation and alignment of the aortic and pulmonary outflows. 8 -10 CNC also interacts with the mesodermal cells of the SHF. 11 When CNC is ablated in the chick embryo, OFT elongation and looping of the cardiac tube is perturbed, leading to persistent truncus arteriosus and misalignment of the great arteries relative to the ventricles. 10 Many signaling pathways in the SHF, CNC, and pharyngeal region control development of the arterial pole of the heart by affecting specification, proliferation, survival and differentiation of progenitor cells. 12 SHF mesoderm also plays a role in the formation of the blood vessels that channel blood from the aorta and pulmonary trunk to the body and lungs. These arteries form within the third, fourth, and sixth pharyngeal arches, which are bilateral embryonic structures, consisting of surface ectoderm, inner endoderm, and a mesodermal core expressing SHF markers, that becomes surrounded by CNC. The endothelium of the pharyngeal arch arteries (PAAs) is formed from the mesodermal core of the arches, whereas the vascular smooth muscle is predominantly CNC-derived. 8, 13, 14 The PAAs form progressively following the anterior/posterior gradient of pharyngeal arch development, and from embryonic day (E)10.5 in the mouse embryo, remodeling leads to the mature PAA system. Many different cellular and genetic perturbations disrupt formation and /or remodeling of the PAAs. 10 Fgf10 was identified as a gene expressed in cells that contribute to the OFT and RV in the mouse embryo, leading to the concept of the SHF. 15 However Fgf10-null mutants have no evident SHF or PAA defects. 16 Fgf8 expression overlaps with that of Fgf10 in the SHF from the cardiac crescent stage. 15 Their expression is restricted to the anterior part of the SHF and is regulated by retinoic acid signaling on the anterior-posterior axis. 17 Fgf10 transcription extends from the anterior SHF into the mesodermal core of the pharyngeal arches, where Fgf8 transcripts are difficult to detect. However, Fgf8
LacZ/ϩ , Fgf8 GFP/ϩ , and Fgf8 enhancer-LacZ transgenic mice show LacZ or green fluorescent protein (GFP) expression in the anterior SHF and the mesodermal core of the arches, implying that Fgf8 is transcribed there. 18 -20 Unlike Fgf10, Fgf8 is also expressed in pharyngeal endoderm and ectoderm, where its expression is maintained, at least until E9.5. 21 Fgf8 mutants die at gastrulation 22 ; however, Fgf8 hypomorphs survive to birth with variable OFT defects including persistent truncus arteriosus, transposition of the great arteries, and pharyngeal arch-related phenotypes. The fourth PAA is most severely affected resulting in interrupted or right aortic arch. 23, 24 Apoptosis of CNC was noted in these hypomorphs, suggesting fibroblast growth factor (FGF)8 signaling defects in surrounding tissues that directly or indirectly affect CNC, because Fgf8 is not expressed in these cells. Subsequently, conditional mutagenesis of Fgf8 with a battery of Cre recombinases, directed to pharyngeal ectoderm, pharyngeal endoderm, and SHF/pharyngeal arch mesoderm, has allowed tissue-specific phenotypes to be determined. 13, 19, 20, 25 Deletion of Fgf8 in the pharyngeal ectoderm leads to CNC apoptosis, affecting PAA development. 25 The role of mesodermal FGF8 in PAA development has not been reported. Mesodermal and endodermal FGF8 are critical for OFT development, affecting the proliferation, survival, and transcriptional activity of SHF cells and their derivatives, in addition to the function of the CNC. Deletion of Fgf8 in early cardiogenic mesoderm with MesP1Cre causes initial OFT/RV hypoplasia and OFT alignment defects in survivors at incomplete penetrance. 19 This implies that FGF10 may compensate for loss of FGF8 in the precardiac mesoderm.
In this study, we generated compound Fgf8 and Fgf10 mutants in the cardiac and pharyngeal mesoderm, using MesP1Cre. We show that PAA development is perturbed by mesodermal Fgf8 deletion. The incidence and severity of PAA and of OFT defects increased with decreasing Fgf8 and Fgf10 gene dosage, resulting in severe defects in double Fgf8;Fgf10 homozygous conditional mutants. These results reveal functional overlap of mesodermal FGF8 and FGF10 during SHF/OFT and PAA development, uncovering for the first time a role for FGF10 in the formation of the arterial pole of the heart. They also illustrate the sensitivity of these processes to incremental reductions in the level of FGF.
Methods

Mouse Lines
Mouse care and procedures were in accordance with institutional and national guidelines. The Fgf8-conditional mutant, Fgf10 mutant, and MesP1Cre alleles are as previously described. 19 
Scoring OFT and RV Morphology
Right-sided views of the OFT and RV in embryos at E9.5 were scored according to four parameters, OFT length, the angle between the proximal and distal regions of the OFT, the size of the RV, and the extent of looping estimated by the angle of the OFT across the ventral body of the embryo. Scoring was performed by two independent observers blinded to genotype. There was remarkably little interobserver variability in the scores of individual embryos of all genotypes (not shown). Embryos were classified as normal, mild, moderate, and severe depending on the score (2 points for each parameter, with a maximum of 8 points: Ͻ2 points, severe; Ͻ4 points, moderate; Ͻ6 points, mild; Ն6, normal).
Histological Analysis and Ink Injection
Longitudinal sections (10 m) were made in the OFT and pharyngeal arch region after paraffin embedding of E10.5 embryos. To visualize PAA formation, India ink was injected into the left ventricle or umbilical vein of E10.5 embryos using drawn glass pipettes.
Quantitative Real-Time PCR
The third to sixth pharyngeal arch region was dissected from embryos at 24 to 26 somite stages and stored in RNAlater (Qiagen) at Ϫ20°C until use. Total RNA was isolated from a pool of six samples for each genotype using RNeasy Mini Kit (Qiagen). The first strand cDNA was synthesized using SuperScript II Reverse Transcriptase (Invitrogen). Quantitative PCR was performed with Power SYBR Green PCR Master Mix (Applied Biosystems) with the StepOnePlus Real-Time PCR system (Applied Biosystems). Reverse transcription and quantitative PCR were repeated 3 times, and Gapdh was used to normalize gene expression. Primer sequences were 5Ј-TGAAAGGCGGATACTTG- 
). In the following text, MesP1
Cre/ϩ is included in all genotypes. Figure 1M ). In contrast, CNC invasion and epithelial-mesenchymal transition were notably compromised in Fgf8;Fgf10 double homozygous mutants ( Figure 1O ) and already affected in Fgf8 flox/flox mutants ( Figure 1N ). To confirm and quantify this, we scored OFT and RV morphology on the basis of OFT length, the angle between the proximal and distal regions of the OFT, RV size and extent of looping, by a blind test. Phenotypes were classified as normal, mild, moderate, and severe, depending on the score (Figure 2A ). The number of abnormal Fgf8 flox/flox embryos was less than in our previous report, probably because in that case the Fgf8 flox/Ϫ cross was analyzed. 19 The important point, shown in Figure 2A , is that increasingly affected embryos were observed as Fgf dosage is reduced. No severe phenotypes were observed with Fgf8 deletion alone, whereas no normal hearts were observed in Fgf8;Fgf10 double homozygous mutants. This result shows that FGF10 functions with FGF8 in OFT and RV development. To verify that FGF signaling was attenuated in Fgf8;Fgf10 double homozygous mutants, we performed quantitative PCR analysis for FGF target genes, Pea3 and Erm, using RNA isolated from the pharyngeal region (including SHF mesoderm, endoderm, ;Fgf10 ϩ/Ϫ mutants, suggesting that FGF8 in pharyngeal endoderm and ectoderm, together with FGF10 from 1 allele of Fgf10 expressed in mesoderm, lead to levels of Pea3 and Erm transcription in the pharyngeal region that obscure the reduction in the mesoderm. However, significant downregulation of the signaling read out from all FGF sources was detected in Fgf8;Fgf10 double homozygous mutants ( Figure 2B ). These results demonstrate the effect on FGF signaling readout of removing both alleles of Fgf10 on an Fgf8 mesodermalnull background. Transcripts for Isl1, a key transcription factor required in the SHF, 29 were also downregulated in the double homozygous mutants ( Figure 2B ). Apoptosis and proliferation were altered in Isl1-positive SHF cells in the double homozygous mutants (Online Figure I, A through D) , as reported for Fgf8 flox/Ϫ mutants, 19 thus explaining the reduction in Isl1 transcripts.
OFT and RV Morphology Is Affected by Reducing
Mesodermal FGF8 and FGF10 Regulate Development of the PAAs
PAAs, visualized by ink injection, were examined in Fgf8;Fgf10 compound mutants at E10.5 (Figure 3) . At this stage, normal mouse embryos have third, fourth, and sixth bilateral PAAs ( Figure 3A through 3C) . PAA development was affected in some Fgf8 flox/flox embryos ( Figure 3D through 3F and 3M). Ectodermal Fgf8 ablation causes bilateral fourth PAA hypoplasia or aplasia. 25 With mesodermal deletion of Fgf8, we observed not only fourth PAA defects but also effects on the development of the third and sixth PAAs and abnormal maintenance of the second PAA ( Figure 3M ). Fgf10 Ϫ/Ϫ mutants did not show any PAA defects, as reported previously (data not shown). 30 However, deletion of one allele of Fgf10 increased the proportion of PAA defects in Fgf8 flox/flox embryos ( Figure 3G through 3I and 3M), and this incidence was further increased in Fgf8;Fgf10 double homozygous mutants ( Figure 3J through 3M) . Apoptosis in CNC was observed at the level of the developing fourth PAA, ;Hoxa3Cre mutants. 23, 25 Sections also illustrated the severe PAA defects seen in Fgf8;Fgf10 double homozygous mutants ( Figure 3O ), compared to control Fgf8;Fgf10 double heterozygous embryos ( Figure 3N ). These results, summarized in Table 1 , show that mesodermal FGF8 and FGF10 are critical for PAA development.
Heart and PAA Phenotypes at Later Developmental Stages Are Consistent With Those Observed Earlier
The adult configuration of the heart and great vessels is largely established by E15.5: the ventricles are separated by the ventricular septum; the OFT has given rise to myocardium at the base of the aorta and pulmonary trunk; and the third, fourth, and sixth PAAs have been remodeled into the common carotid and subclavian arteries and contributed to part of the aortic arch and ductus arteriosus ( Figure 4A and 4B ). In the heart of Fgf8 flox/flox embryos, as previously reported, 19 transposition of the great arteries, double outlet right ventricle (DORV), and ventricular septal defects (VSDs) were observed, although in a minority of cases (Figure 4F and 4G;  Table 2 ). In Fgf8 flox/flox ;Fgf10 compound mutants, these heart defects became more frequent as Fgf10 dosage is reduced ( Figure 4J , 4L, and 4M; Table 2 ). Defects in PAA derivatives reflect the PAA abnormalities seen in mutants at E10.5. We observed absence of the left common carotid artery ( Figure  4E , 4H, and 4K), which was attributable to loss of the left third PAA; aberrant origin of the right subclavian artery ( Figure 4F , 4I, and 4K), which is attributable to loss of the right fourth PAA; right aortic arch ( Figure 4I ), which is caused by loss of the left fourth PAA (the aortic arch is probably replaced by the right fourth PAA); and narrow aortic arch ( Figure 4L ), because of a hypoplastic left fourth PAA. Consistent with earlier defects of the heart and PAA, the incidence of these later defects in surviving embryos was significantly increased when Fgf10 gene dosage was reduced, in conjunction with mesodermal deletion of Fgf8 (Table 2) . These results confirm the functional overlap of mesodermal FGF8 and FGF10 in the development of the arterial pole of the heart and PAA, seen at earlier stages.
Discussion
The phenotypic analysis that we present establishes a role for FGF10 as well as FGF8 in the formation of the arterial pole of the heart and demonstrates that this process is highly sensitive to FGF dosage. Furthermore, we show that the level of FGF8 and FGF10 signaling is not only critical for OFT development, but also for the PAAs and their derivatives. Unexpectedly, mesodermal, as well as ectodermal, 25 expression of Fgf8 is important for the correct formation of these arteries and thus for cardiac function.
Most of the mutant embryos survive to late fetal stages, permitting analysis of the definitive morphology of the arterial pole. This is in contrast to previously reported observations on Fgf8 flox/Ϫ
;MesP1
Cre/ϩ embryos of which 65% died by E10.5. 19 This difference probably reflects the mesodermal specificity of deletion of the floxed alleles, which in our case (Fgf8
Cre/ϩ ) are entirely responsible for generating the mutant phenotype. At early stages, in Fgf8 and in Fgf8;Fgf10 mutants, we observe hypoplasia of both the OFT and RV, which also derives from SHF cells expressing Fgf8, 15, 20 as well as Fgf10. 15 This reflects apoptosis and loss of proliferation of progenitor cells, observed when FGF signaling is abrogated, attributable either to mutation of mesodermal Fgf8 and Fgf10 (in this study) 19 or to interference with FGF signal reception in the SHF. 31, 32 A reduction in SHF cells is also indicated by a decrease in Isl1 expression, reported for the more severe 
;Fgf10
Ϫ/Ϫ double mutants. As the OFT matures, leading to epithelial-mesenchymal transition, cushion formation is initiated and CNC migrates into the OFT. These processes are affected when FGF signaling in mesoderm is abrogated, 31, 32 in CNC is diminished. 31, 32 We propose that the Bmp/TGF␤ pathway mediates the action of mesodermal FGF signaling on CNC, because components of this pathway are downregulated in Fgf8 mutants. 31 This would also have effects on the Nkx2.5 transcriptional network in the SHF. 33 Further identification of targets of Pea3/Erm, transcriptional effectors of FGF signaling, should provide more insight into the FGF regulatory network. Failure of CNC migration into the OFT probably results from abnormal cell death in the pharyngeal arches. 20, [23] [24] [25] Upregulation of FGF signaling, observed with CNC ablation 34 or in Tbx3 mutants, 35 also disrupts OFT development, demonstrating a critical requirement for precise levels of FGF signaling during arterial pole formation. Because CNC contributes the smooth muscle of the nascent PAAs and their mature derivatives, CNC death in Fgf8; Fgf10;MesP1Cre compound mutants contributes to defects in the stabilization and remodeling of these arteries. In ; AP2␣IresCre mutants where Fgf8 was deleted in pharyngeal ectoderm, major defects in the fourth PAA were documented, with minor effects on third and sixth PAAs. 25 Fgf8 deletion in the mesodermal core of the arches causes similar effects on third, fourth and sixth PAAs. The increase in PAA defects in Fgf8 flox/flox ; Fgf10 Ϫ/Ϫ double mutants reveals an unsuspected role for FGF10 in PAA development. We also observe some cases of second PAA persistence at E10.5, probably reflecting a developmental delay. Mesodermal FGF signaling is clearly also necessary and the timing of this requirement may precede the appearance of CNC. MesP1Cre is activated at about E6.5, well before somites begin to form, whereas the Mef2c regulatory element that drives Mef2cCre expression in the SHF, including pharyngeal arch mesoderm, is activated later, from 2 to 3 somite stages. 19 Because PAA formation and remodeling are normal in Cardiac defects in surviving Fgf8;Fgf10 mutants, present as alignment defects of the aorta and pulmonary trunk (transposition of the great arteries) together with DORV and VSDs, reflecting earlier malpositioning of the OFT and affected CNC. These defects also predominate when mesodermal Fgf8 is mutated (Table 2) , whereas persistent truncus arteriosus is seen when Fgf8 is deleted in both mesoderm and pharyngeal endoderm. 13, 19 The defects that we observe later in carotid and subclavian arteries and in the aortic arch reflect earlier defects in PAA development. When Fgf8 is deleted in pharyngeal ectoderm, 25 the range and frequency of defects is different from those observed with mesodermal deletion of Fgf8, or when Fgf10 is also mutated. In addition to dose dependence, this result reveals the importance of paracrine effects of FGF signaling during PAA development. Deletion of Fgf8 and Fgf10 does not result in total loss of the structures that depend on FGF signaling. This may be because other signaling pathways, such as Bmp/TGF␤, which lies downstream of FGF8, 19 also function independently to promote formation of the arterial pole of the heart and the PAAs. It may also reflect the ability of other FGFs to compensate in the SHF and pharyngeal arches. Fgf15, for example, is expressed in pharyngeal mesoderm and Fgf15 mutants have cardiac defects (DORV, overriding aorta and VSD), suggesting that FGF15 may play a role in the development of the arterial pole of the heart. 36 Loss of Fgf3, which is also expressed in pharyngeal endoderm, does not cause heart or PAA phenotypes, but Fgf3
mutants have an aberrant origin of the right subclavian artery and interrupted aortic arch. 37 In considering the relative roles of FGF8 and FGF10, the former is more widely produced, by pharyngeal endoderm and pharyngeal ectoderm, as well as by mesoderm in the anterior SHF and in its extension into the core of the pharyngeal arches, whereas FGF10 production is predominantly limited to the mesoderm. Both FGFs bind to FGF receptor (FGFR)2, although FGF10 binds preferentially to the IIIb isoform, whereas FGF8 binds to IIIc and also has affinity for FGFR1, FGFR3IIIc, and FGFR4. 38 -40 Mutational analysis of Fgfr1 and Fgfr2 suggests that FGFR1 is the dominant receptor in the SHF, 31 although FGFR2 is also active and indeed in a different genetic background may be more important. 32 Mutation of Fgfr1 and Fgfr2 in mesoderm compromises OFT development, as does overexpression of Sprouty2, an inhibitor of intracellular FGF signaling. 31 Examination of Fgfr2-IIIb mutants shows later cardiac defects, 16 but no striking effects on the early OFT, although RV hypoplasia, overriding aorta, DORV, and VSDs were noted. The question of in vivo FGF/receptor specificity is complex and the only clear conclusion to date is that FGFR1 and FGFR2 are required for FGF8 and FGF10 signaling, playing an essential role in the control of SHF progenitor cell proliferation and downstream signaling cascades 31 during OFT morphogenesis.
The Tbx1 mutant phenotype, which recapitulates cardiovascular aspects of human DiGeorge syndrome, [41] [42] [43] overlaps with that of Fgf8 hypomorphs. 23, 24 Tbx1 is expressed in the mesoderm of the anterior SHF, including the mesodermal core, endoderm, and ectoderm of the pharyngeal arches, 44, 45 like Fgf8. Genetic analysis suggests that Tbx1 lies upstream of Fgf8 in pharyngeal endoderm 46 and also affects Fgf8 and Fgf10 expression in SHF mesoderm. 18, 46, 47 Phenotypic analysis of embryos after tissue specific deletion of Tbx1 with mesodermal Cre lines has shown that mesodermal Tbx1 is critical for SHF and OFT development. 48 This is similar to FGF8 19 and to FGF10 as we now show.
Our findings demonstrate for the first time that mesodermal FGF10, as well as FGF8, is important for formation of the arterial pole of the heart and the PAAs, providing new insight into the cardiovascular abnormalities seen in Di- George syndrome. Furthermore, mutations in Fgf10 and Fgf8 that affect their expression in pharyngeal mesoderm may underlie human congenital heart and vascular defects.
Novelty and Significance
What Is Known?
• FGF8 signaling from pharyngeal ectoderm is required for correct formation of great arteries.
• FGF8 from second heart field mesoderm is required for arterial pole formation.
• Fgf10, like Fgf8, is expressed in mesodermal cells of the second heart field.
• Fgf10 mutants have no detectable great artery or arterial pole defects.
What New Information Does This Article Contribute?
• It reveals a new role of FGF10 in formation of the arterial pole of the heart, when FGF8 is reduced or abolished.
• It reveals a previously unexpected role for mesodermal FGF8 function in great vessel development.
More than 30% of congenital heart defects affect development of the arterial pole of the heart. In the mammalian embryo, cells that will contribute to this part of the heart derive from mesoderm of the second heart field. Loss of Fgf8 function in these cells leads to arterial pole defects. Fgf10 is also expressed in the second heart field, yet Fgf10 mutants do not have detectable outflow tract or great vessel defects. This may be attributable to compensation by fibroblast growth factor (FGF)8.
To address this question, we examined compound mutants and show that arterial pole defects are more severe in the absence of both Fgf8 and Fgf10 function in the second heart field. This is also the case for arch arteries that contribute connecting vessels, such as the subclavian and common carotid arteries, revealing for the first time a role for mesodermal FGF8 and FGF10 in vascular development. Our compound mutant analysis also demonstrates that this requirement is highly dosage sensitive, such that progressive reduction in the number of functional alleles of Fgf8 and Fgf10 leads to increasingly severe defects. These findings identify Fgf8 and Fgf10 as candidate genes for congenital cardiovascular malformations in the human population.
